Patent details

EP1804816 Title: COMBINATION THERAPY COMPRISING CLORETAZINE(TM)

Basic Information

Publication number:
EP1804816
PCT Application Number:
PCT/US/2005/010152
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP057453573
PCT Publication Number:
WO/2005/094282
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION THERAPY COMPRISING CLORETAZINE(TM)
French Title of Invention:
THERAPIE COMBINATOIRE COMPRENANT LA CLORETAZINE(TM)
German Title of Invention:
KOMBINATIONSTHERAPIE MIT KLORETAZIN(TM)
SPC Number:

Dates

Filing date:
25/03/2005
Grant date:
21/12/2011
EP Publication Date:
21/12/2011
PCT Publication Date:
13/10/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/07/2007
EP B1 Publication Date:
21/12/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
25/03/2012
Expiration date:
25/03/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/05/2012
 
 

Name:
Nanotherapeutics Inc.
Address:
13859 Progress Blvd. Suite 300, Alachua, FL 32615, United States (US)

Inventor

1

Name:
BELCOURT Michael
Address:
United States (US)

2

Name:
SZNOL Mario
Address:
United States (US)

3

Name:
KING Ivan
Address:
United States (US)

4

Name:
ZHENG Li-Mou
Address:
United States (US)

Priority

Priority Number:
556565 P
Priority Date:
26/03/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/00;
Filing date Document type Number of pages